ArticleCureus2026
Association of Cardiac Autonomic Dysfunction and Cognitive Impairment With Disease Severity in Parkinson's Disease: A Cross-Sectional Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Parkinson's disease (PD) is a neurodegenerative disorder characterized by the presence of both motor and non-motor features. Although cardiac autonomic imbalance and cognitive derangement are well documented in PD, their relationship with the severity of the disease has not been explored using a multimodal approach. Objective This study aimed to assess the correlation between cardiac autonomic function, cognitive parameters (P300 and reaction time), and biochemical markers (homocysteine (HCY) and 8-hydroxy-2'-deoxyguanosine (8-OHdG)) with disease severity in individuals with mild-to-moderate PD. Methods Forty individuals aged 35 to 70 years diagnosed with PD were recruited. Cardiac autonomic function was assessed using heart rate variability (HRV) analysis and conventional autonomic function tests. Cognitive function was evaluated by recording P300 event-related potentials and auditory and visual reaction time. Serum HCY and serum 8‑OHdG were measured as biomarkers of cardiovascular risk and oxidative stress, respectively, using ELISA. Disease severity was assessed using the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Part III. Correlation between the study parameters was assessed using the Pearson or Spearman's rank correlation coefficient test. P<0.05 was considered statistically significant. Results Significant positive correlations were observed between UPDRS scores and HRV indices of sympathetic activity (LF power, LFnu), sympathovagal balance (LF/HF), P300 latency, reaction times, and biomarker levels. Significant negative correlations were observed between UPDRS scores and parasympathetic HRV indices (HF power, HF nu), total HRV, conventional autonomic function parameters, and P300 amplitude. Conclusion Increasing disease severity in PD is associated with cardiac autonomic imbalance, cognitive impairment, and elevated markers of cardiovascular risk and oxidative stress, suggesting a multi-system involvement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.